Cipher Pharmaceuticals Inc.

TSX:CPH Rapporto sulle azioni

Cap. di mercato: CA$327.5m

Cipher Pharmaceuticals Gestione

Gestione criteri di controllo 2/4

Cipher Pharmaceuticals Il CEO è Craig Mull, nominato in Jul2019, ha un mandato di 5.33 anni. possiede direttamente 3.19% delle azioni della società, per un valore di CA$ 10.46M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 2.5 anni e 3.5 anni.

Informazioni chiave

Craig Mull

Amministratore delegato

US$1.0m

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEO5.3yrs
Proprietà del CEO3.2%
Durata media del management2.5yrs
Durata media del Consiglio di amministrazione3.5yrs

Aggiornamenti recenti sulla gestione

Recent updates

Cipher Pharmaceuticals' (TSE:CPH) Anemic Earnings Might Be Worse Than You Think

Nov 14
Cipher Pharmaceuticals' (TSE:CPH) Anemic Earnings Might Be Worse Than You Think

With A 29% Price Drop For Cipher Pharmaceuticals Inc. (TSE:CPH) You'll Still Get What You Pay For

Nov 12
With A 29% Price Drop For Cipher Pharmaceuticals Inc. (TSE:CPH) You'll Still Get What You Pay For

Cipher Pharmaceuticals Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Nov 09
Cipher Pharmaceuticals Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

There's No Escaping Cipher Pharmaceuticals Inc.'s (TSE:CPH) Muted Earnings Despite A 26% Share Price Rise

Mar 23
There's No Escaping Cipher Pharmaceuticals Inc.'s (TSE:CPH) Muted Earnings Despite A 26% Share Price Rise

Weak Statutory Earnings May Not Tell The Whole Story For Cipher Pharmaceuticals (TSE:CPH)

Mar 22
Weak Statutory Earnings May Not Tell The Whole Story For Cipher Pharmaceuticals (TSE:CPH)

Here's Why I Think Cipher Pharmaceuticals (TSE:CPH) Is An Interesting Stock

May 14
Here's Why I Think Cipher Pharmaceuticals (TSE:CPH) Is An Interesting Stock

Analysts Just Published A Bright New Outlook For Cipher Pharmaceuticals Inc.'s (TSE:CPH)

May 18
Analysts Just Published A Bright New Outlook For Cipher Pharmaceuticals Inc.'s (TSE:CPH)

Cipher Pharmaceuticals Inc. Just Missed EPS By 37%: Here's What Analysts Think Will Happen Next

Mar 20
Cipher Pharmaceuticals Inc. Just Missed EPS By 37%: Here's What Analysts Think Will Happen Next

Industry Analysts Just Upgraded Their Cipher Pharmaceuticals Inc. (TSE:CPH) Revenue Forecasts By 12%

Jan 26
Industry Analysts Just Upgraded Their Cipher Pharmaceuticals Inc. (TSE:CPH) Revenue Forecasts By 12%

AMMINISTRATORE DELEGATO

Craig Mull

5.3yrs

Mandato

US$1,045,700

Compensazione

Mr. Craig J. Mull has been Chairman of the Board of Directors at Cipher Pharmaceuticals Inc. since June 11, 2019 and its Interim Chief Executive Officer since July 29, 2019, served as its President. Mr. Mu...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Craig Mull
Interim CEO & Chairman of the Board5.3yrsUS$1.05m3.19%
CA$ 10.5m
Bryan Jacobs
Chief Financial Officer2.3yrsUS$391.35k0.020%
CA$ 64.0k
Emilio Presti
Director of Sales & Marketing2.8yrsNessun datoNessun dato
Hamed Ghanei
Chief Business Officerless than a yearNessun datoNessun dato

2.5yrs

Durata media

Gestione esperta: Il team dirigenziale di CPH è considerato esperto (durata media dell'incarico 2.5 anni).

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Craig Mull
Interim CEO & Chairman of the Board5.7yrsUS$1.05m3.19%
CA$ 10.5m
Harold Wolkin
Lead Independent Director8.3yrsUS$73.49k1.43%
CA$ 4.7m
Douglas Deeth
Independent Director1.4yrsUS$65.57kNessun dato
Hubert Walinski
Independent Director1.4yrsUS$62.57kNessun dato

3.5yrs

Durata media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di CPH sono considerati esperti (durata media dell'incarico 3.5 anni).